查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1624434

研究用抗体的全球市场规模:各技术，各终端用户，各产品，各用途，各地区，范围及预测

Global Research Antibodies Market Size By Technology, By End User, By Product, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

研究抗体的市场规模及预测

2021 年研究抗体市场规模价值 108.7 亿美元，预计到 2030 年将达到 195.5 亿美元，2023 年至 2030 年的复合年增长率为 6.75%。各国政府为蛋白质体学和基因组学研究提供了巨额资金，从而带动全球研究抗体市场蓬勃发展。全球研究抗体市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

全球研究抗体市场定义

B 细胞产生的蛋白质称为抗体。这些 B 细胞是人体免疫系统的一部分。抗体的主要功能是附着于抗原并标记它以供破坏。这有助于抵抗感染。研究抗体可以与特定分子结合，使其成为研究细胞的理想探针。研究抗体是研究细胞内蛋白质功能的重要工具。

全球研究抗体市场概论

全球研究抗体市场的成长是由不断增加的研究活动所推动的。公司对研发活动投入了大量资金。产学合作的加强也促进了全球研究抗体市场的快速成长。印度和中国等新兴市场预计将为市场成长创造新的机会。然而，与上述推动因素相反，也存在一些限制市场成长的因素。对结果品质和缺乏可重复性的担忧可能会对市场成长产生负面影响。

目录

第1章 全球研究用抗体市场简介

  • 市场概要
  • 调查范围
  • 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源一览

第4章 全球研究用抗体市场展望

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力分析
  • 价值链分析
  • 法律规范

第5章 研究用抗体的全球市场:各技术

  • 西方印渍术
  • 流式细胞技术
  • 酵素结合免疫吸附检测法(ELISA)
  • 免疫组织化学
  • 免疫萤光法
  • 免疫沉淀
  • 其他技术

第6章 研究用抗体的全球市场:各终端用户

  • 製药·生物科技企业
  • 学术·研究机关
  • 受託研究机构

第7章 研究用抗体的全球市场:各产品

  • 试剂
    • 培养基·血清
    • 染色·色素
    • 固定化剂
    • 缓衝液
    • 溶媒
    • 酵素
    • 探针
    • 其他的试剂
  • 抗体
    • 各类型
    • 各来源
    • 各研究领域

第8章 研究用抗体的全球市场:各用途

  • 蛋白质体学
  • 医药品开发
  • 基因学

第9章 研究用抗体的全球市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 全球其他地区
    • 南美
    • 中东·非洲

第10章 全球研究用抗体市场竞争情形

  • 概要
  • 各公司的市场占有率
  • 业者情势
  • 主要的开发策略

第11章 企业简介

  • Thermo Fisher Scientific Inc.
  • Merck Group
  • Abcam PLC
  • Becton, Dickinson and Company
  • Cell Signaling Technology, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Lonza
  • Genscript
  • Perkinelmer, Inc.
  • Biolegend, Inc.

第12章 主要发展

  • 产品的上市/开发
  • 合併和收购
  • 事业扩大
  • 伙伴关係和合作

第13章 附录

  • 相关调查
简介目录
Product Code: 24330

Research Antibodies Market Size And Forecast

Research Antibodies Market size was valued at USD 10.87 Billion in 2021 and is projected to reach USD 19.55 Billion by 2030, growing at a CAGR of 6.75% from 2023 to 2030. The governments are providing huge funds to proteomics and genomics research and that has led to the global Research Antibodies Market growing at a rapid pace. The Global Research Antibodies Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Research Antibodies Market Definition

The proteins which are made up of B cells are called antibodies. These B cells are part of the body's immune system. The primary function of the antibodies is to latch on to antigens and flag them for destruction. This helps in fighting infection. The research antibodies can bind specific molecules which makes them ideal probes in cell research. Research antibodies are an important tool when it comes to studying protein functions in cells.

Global Research Antibodies Market Overview

The growth of the Global Research Antibodies Market is being driven by increasing research activities. The companies are investing heavily in research and development activities. The growing industry-academia collaboration has also led to the rapid growth of the Global Research Antibodies Market. Emerging markets such as India and China will create new opportunities for the market to grow. However, contrary to the above drivers some restraints will limit the growth of the market. The concerns related to quality and lack of reproducible results will negatively influence the growth of the market.

Global Research Antibodies Market: Segmentation Analysis

The Global Research Antibodies Market is Segmented on the basis of Technology, End User, Product, Application, And Geography.

Research Antibodies Market, By Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

Based on Technology, the market is bifurcated into Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and Other Technologies. The flow cytometry segment is dominating the market owing to its ability to perform simultaneous multi-parameter analysis on a single cell within a heterogeneous mixture.

Research Antibodies Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Based on End User, the market is bifurcated into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations. The pharmaceutical and biotechnology companies contributed majorly to the growth of the market as research antibodies are widely being used for drug development.

Research Antibodies Market, By Product

  • Reagents
  • Antibodies

Based on Product, the market is bifurcated into Reagents and Antibodies. The reagents segment is further bifurcated into Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, and Other Reagents. The antibodies segment is further bifurcated into By Type, By Source, and By Research Area.

Research Antibodies Market, By Application

  • Proteomics
  • Drug Development
  • Genomics

Based on Application, the market is bifurcated into Proteomics, Drug Development, and Genomics. The proteomics segment dominated the market as it was able to effectively minimize the cost, time, and resource requirement for chemical synthesis and biological testing of drugs.

Research Antibodies Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Research Antibodies Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America. The dominance of the North American region is credited to the increasing investment in the development of structure-based drug designs.

Key Players

  • The "Global Research Antibodies Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Thermo Fisher Scientific Inc., Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Danaher Corporation, Lonza, Genscript, Perkinelmer, Inc., Biolegend, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Partnerships, Collaborations and Agreements
  • In 2018, Thermo Fisher Scientific Inc., collaborated with Montreal Neurological Institute with an aim to develop improved and new methods to both characterize and produce antibodies for advanced neurological research associated with Amyotrophic lateral sclerosis, Parkinson's disease, and other brain diseases.
  • In 2020, Thermo Fisher Scientific (US) collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies.
  • Mergers and Acquisitions
  • On September 2018, Roche announced the acquisition of Tusk Therapeutic Ltd. Tusk is a developer of an antibody that has a novel mode of action aimed at depleting regulatory T cells.
  • In 2019, Thermo Fisher Scientific (US) acquired Brammer Bio (US) to expand its capacity for manufacturing viral vectors for gene and cell therapies with Brammer Bio's CDMO facilities. The acquisition was valued at USD 1.7 billion.
  • Product Launches and Product Expansions
  • On October 2021, Thermo Fisher Scientific, the world leader in serving science, has launched a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0. expands Thermo Fisher's menu of highly accurate tests that detect active SARS-CoV-2 infections.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RESEARCH ANTIBODIES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RESEARCH ANTIBODIES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY

  • 5.1 Western Blotting
  • 5.2 Flow Cytometry
  • 5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
  • 5.4 Immunohistochemistry
  • 5.5 Immunofluorescence
  • 5.6 Immunoprecipitation
  • 5.7 Other Technologies

6 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER

  • 6.1 Pharmaceutical and Biotechnology Companies
  • 6.2 Academic and Research Institutes
  • 6.3 Contract Research Organizations

7 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT

  • 7.1 Reagents
    • 7.1.1 Media & Sera
    • 7.1.2 Stains & Dyes
    • 7.1.3 Fixatives
    • 7.1.4 Buffers
    • 7.1.5 Solvents
    • 7.1.6 Enzymes
    • 7.1.7 Probes
    • 7.1.8 Other Reagents
  • 7.2 Antibodies
    • 7.2.1 By Type
    • 7.2.1.1 Primary Antibodies
    • 7.2.1.2 Secondary Antibodies
    • 7.2.2 By Source
    • 7.2.2.1 Mice
    • 7.2.2.2 Rabbits
    • 7.2.2.3 Other Sources
    • 7.2.3 By Research Area
    • 7.2.3.1 Oncology
    • 7.2.3.2 Infectious Diseases
    • 7.2.3.3 Immunology
    • 7.2.3.4 Neurobiology
    • 7.2.3.5 Stem Cells
    • 7.2.3.6 Other Research Areas

8 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION

  • 8.1 Proteomics
  • 8.2 Drug Development
  • 8.3 Genomics

9 GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East and Africa

10 GLOBAL RESEARCH ANTIBODIES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Share
  • 10.3 Vendor Landscape
  • 10.4 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Thermo Fisher Scientific Inc.
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Merck Group
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Abcam PLC
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 Becton, Dickinson and Company
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Cell Signaling Technology, Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Bio-Rad Laboratories, Inc.
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 F. Hoffmann-La Roche Ltd
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Agilent Technologies, Inc.
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 Danaher Corporation
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments
  • 11.10 Lonza
    • 11.10.1 Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Outlook
    • 11.10.4 Key Developments
  • 11.11 Genscript
    • 11.11.1 Overview
    • 11.11.2 Financial Performance
    • 11.11.3 Product Outlook
    • 11.11.4 Key Developments
  • 11.12 Perkinelmer, Inc.
    • 11.12.1 Overview
    • 11.12.2 Financial Performance
    • 11.12.3 Product Outlook
    • 11.12.4 Key Developments
  • 11.13 Biolegend, Inc.
    • 11.13.1 Overview
    • 11.13.2 Financial Performance
    • 11.13.3 Product Outlook
    • 11.13.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research